Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Medical Condition: Leber’s Hereditary Optic Neuropathy / LHON is a maternally inherited loss of vision due to atrophy of the optic nerve. It typically presents in young adults, mostly men, as painless acute or subacute visual failure of both eyes in quick succession. The estimated prevalence is approximately 2.2 per 100,000 (Mascialino et al., 2012) and LHON is thus an Orphan Disease according to EU and US criteria. MedDRA version: 20.1Level: LLTClassification code 10062951Term: Leber's hereditary optic atrophy neuropathySystem Organ Class: 100000004850;Therapeutic area: Diseases [C] - Eye Diseases [C11]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%2522Prevalence%2522&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Leber%E2%80%99s+Hereditary+Optic+Neuropathy+%2F+LHON+is+a+maternally+inherited+loss+of+vision+due+to+atrophy+of+the+optic+nerve.+It+typically+presents+in+young+adults%2C+mostly+men%2C+as+painless+acute+or+subacute+visual+failure+of+both+eyes+in+quick+succession.+The+estimated+prevalence+is+approximately+2.2+per+100%2C000+%28Mascialino+et+al.%2C+2012%29+and+LHON+is+thus+an+Orphan+Disease+according+to+EU+and+US+criteria.+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10062951Term%3A+Leber%27s+hereditary+optic+atrophy+neuropathySystem+Organ+Class%3A+100000004850%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Eye+Diseases+%5BC11%5D%22
/vufind/Search/Results?lookfor=%2522Prevalence%2522&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Leber%E2%80%99s+Hereditary+Optic+Neuropathy+%2F+LHON+is+a+maternally+inherited+loss+of+vision+due+to+atrophy+of+the+optic+nerve.+It+typically+presents+in+young+adults%2C+mostly+men%2C+as+painless+acute+or+subacute+visual+failure+of+both+eyes+in+quick+succession.+The+estimated+prevalence+is+approximately+2.2+per+100%2C000+%28Mascialino+et+al.%2C+2012%29+and+LHON+is+thus+an+Orphan+Disease+according+to+EU+and+US+criteria.+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10062951Term%3A+Leber%27s+hereditary+optic+atrophy+neuropathySystem+Organ+Class%3A+100000004850%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Eye+Diseases+%5BC11%5D%22
Search /vufind/Search2/Results?lookfor=%2522Prevalence%2522&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Leber%E2%80%99s+Hereditary+Optic+Neuropathy+%2F+LHON+is+a+maternally+inherited+loss+of+vision+due+to+atrophy+of+the+optic+nerve.+It+typically+presents+in+young+adults%2C+mostly+men%2C+as+painless+acute+or+subacute+visual+failure+of+both+eyes+in+quick+succession.+The+estimated+prevalence+is+approximately+2.2+per+100%2C000+%28Mascialino+et+al.%2C+2012%29+and+LHON+is+thus+an+Orphan+Disease+according+to+EU+and+US+criteria.+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10062951Term%3A+Leber%27s+hereditary+optic+atrophy+neuropathySystem+Organ+Class%3A+100000004850%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Eye+Diseases+%5BC11%5D%22
PubPharm (12)
1
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Clinical study to assess the effectiveness and safety of Raxone during long time treatment in patients with LHON : External Natural History Controlled, open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment with Raxone® in Leber’s Hereditary Optic Neuropathy (LHON) - (LEROS) Open- Label Study to assess the Efficacy and Safety of Raxone in LHON Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Leber’s Hereditary Optic Neuropathy / LHON is a maternally inherited loss of vision due to atrophy of the optic nerve. It typically presents in young adults, mostly men, as painless acute or subacute visual failure of both eyes in quick succession. The estimated prevalence is approximately 2.2 per 100,000 (Mascialino et al., 2012) and LHON is thus an Orphan Disease according to EU and US criteria. MedDRA version: 20.1Level: LLTClassification code 10062951Term: Leber's hereditary optic atrophy neuropathySystem Organ Class: 100000004850;Therapeutic area: Diseases [C] - Eye Diseases [C11]
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
12
WHO International Clinical Trials Registry Plat...
Thema
12
610
Medical Condition: Leber’s Hereditary Optic N...
12
Phase: Phase 4
12
Recruitment Status: Not yet recruiting
12
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2022
8
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...